Concepedia

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1

Jonathan M. Meyer, Vicki G. Davis, Joseph P. McEvoy, Donald Goff, Henry A. Nasrallah, Sonia M. Davis, Gail L. Daumit, John Hsiao, Marvin S. Swartz, T. Scott Stroup,

Schizophrenia Research · 2008 · 74 citations · 11 references

DOIFull text

Open access

Concepts

References

11

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy et al. · New England Journal of Medicine · 2005 · 5.9K citations · Full text

, , +14

Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women

Børge G. Nordestgaard, Marianne Benn, Peter Schnohr et al. · JAMA · 2007 · 2.1K citations

, , +16

Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women

Sandeep Bansal, Julie E. Buring, Nader Rifai et al. · JAMA · 2007 · 1.6K citations

, , +13

Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

Joseph P. McEvoy, Jonathan M. Meyer, Donald Goff et al. · Schizophrenia Research · 2005 · 1.1K citations

, , +10

Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant

Tracey McLaughlin, Fahim Abbasi, Karen Cheal et al. · Annals of Internal Medicine · 2003 · 1K citations

, , +13